Temporal fluctuation of multidrug resistant Salmonella typhi haplotypes in the mekong river delta region of Vietnam

PLoS Neglected Tropical Diseases

Volumn 5, Issue 1, 2011, Pages

  Holt, Kathryn E ^a,b   Dolecek, Christiane ^c,d,e   Chau, Tran Thuy ^c   Duy, Pham Thanh ^c   la, Tran Thi Phi ^f   van Minh Hoang, Nguyen ^c   Nga, Tran Vu Thieu ^c   Campbell, James I ^c,d   Manh, Bui Huu ^c   van Vinh Chau, Nguyen ^g   Hien, Tran Tinh ^g   Farrar, Jeremy ^c,d   Dougan, Gordon ^a   Baker, Stephen ^c,d  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f An Giang Provincial Hospital   (Viet Nam)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NALIDIXIC ACID; OFLOXACIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLONAL SPECIES; CONTROLLED STUDY; EPIDEMIC; GENETIC VARIABILITY; HAPLOTYPE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; POPULATION GENETIC STRUCTURE; SALMONELLA TYPHI; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES IDENTIFICATION; TYPHOID FEVER; VIET NAM; ADULT; CHEMISTRY; CHILD; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENETICS; GENOTYPE; HIGH THROUGHPUT NUCLEOTIDE SEQUENCING; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MULTICENTER STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HAPLOTYPES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; MALE; PLASMIDS; SALMONELLA TYPHI; TYPHOID FEVER; VIETNAM;

EID: 79851504748     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000929     Document Type: Article

References (28)

1. Kelly-Hope LA, Alonso WJ, Thiem VD, Canh do G, Anh DD, et al. (2008) Temporal trends and climatic factors associated with bacterial enteric diseases in Vietnam, 1991-2001. Environ Health Perspect 116: 7-12.
2. Kelly-Hope LA, Alonso WJ, Thiem VD, Anh DD, Canh do G, et al. (2007) Geographical distribution and risk factors associated with enteric diseases in Vietnam. Am J Trop Med Hyg 76: 706-712.
3. Lin FY, Vo AH, Phan VB, Nguyen TT, Bryla D, et al. (2000) The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 62: 644-648.
4. Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, et al. (2001) The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 344: 1263-1269.
5. Connerton P, Wain J, Hien TT, Ali T, Parry C, et al. (2000) Epidemic typhoid in vietnam: molecular typing of multiple-antibiotic-resistant Salmonella enterica serotype typhi from four outbreaks. J Clin Microbiol 38: 895-897.
6. Kariuki S, Revathi G, Muyodi J, Mwituria J, Munyalo A, et al. (2004) Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol 42: 1477-1482.
7. Taylor DE, Brose EC (1985) Characterization of incompatibility group HI1 plasmids from Salmonella typhi by restriction endonuclease digestion and hybridization of DNA probes for Tn3, Tn9, and Tn10. Can J Microbiol 31: 721-729.
8. Hermans PW, Saha SK, van Leeuwen WJ, Verbrugh HA, van Belkum A, et al. (1996) Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J Clin Microbiol 34: 1373-1379.
9. Shanahan PM, Karamat KA, Thomson CJ, Amyes SG (2000) Characterization of multi-drug resistant Salmonella typhi isolated from Pakistan. Epidemiol Infect 124: 9-16.
10. Wain J, Diem Nga LT, Kidgell C, James K, Fortune S, et al. (2003) Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 47: 2732-2739.
11. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, et al. (2007) Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 51: 4315-4323.
12. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, et al. (2006) Evolutionary history of Salmonella typhi. Science 314: 1301-1304.
13. Biologicals WHODoVa (2003) Background document: the diagnosis, prevention and treatment of typhoid fever. World Health Organization.
14. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, et al. (2000) A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 44: 1855-1859.
15. Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, et al. (1997) Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25: 1404-1410.
16. Capoor MR, Nair D, Hasan AS, Aggarwal P, Gupta B (2006) Typhoid fever: narrowing therapeutic options in India. Southeast Asian J Trop Med Public Health 37: 1170-1174.
17. Clinical and Laboratory Standards Institute (2007) Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth International Supplement; Vol. 27 (No. 1).
18. Parry CM (2004) The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 98: 413-422.
19. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, et al. (2008) Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 52: 1278-1284.
20. Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, et al. (2008) A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 3: e2188.
21. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, et al. (2008) High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 40: 987-993.
22. Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, et al. (2010) Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 48: 2171-2176.
23. Holt KE, Baker S, Dongol S, Basnyat B, Adhikari N, et al. (2010) High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect Dis 10: 144.
24. Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, et al. (2009) Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother 53: 716-727.
25. Stamatakis A, Ludwig T, Meier H (2005) RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456-463.
26. Hopkins KL, Davies RH, Threlfall EJ (2005) Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25: 358-373.
27. Baker S, Holt K, van de Vosse E, Roumagnac P, Whitehead S, et al. (2008) High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia. J Clin Microbiol 46: 1741-1746.
28. Luxemburger C, Chau MC, Mai NL, Wain J, Tran TH, et al. (2001) Risk factors for typhoid fever in the Mekong delta, southern Viet Nam: a case-control study. Trans R Soc Trop Med Hyg 95: 19-23.